₹81.55Original price was: ₹81.55.82.51Current price is: ₹82.51.
Atomoxetine 10mg Tablet is a medication primarily used to treat Attention-Deficit Hyperactivity Disorder (ADHD) and the associated symptoms of ADHD in adults and children over the age of 12.
Atomoxetine 10mg Tablet is an active ingredient in Strattera 10mg Tablet which belongs to a class of drugs known as atypical antipsychotics. It works by increasing the levels of norepinephrine in the brain, thereby enhancing focus, impulse control and impulse control difficulties in individuals with ADHD.
Key Features:
Why Choose Atomoxetine 10mg Tablet?
>
How to use:
How to store:
Safety Information:
Warnings:
FAQs:
Q: Can Atomoxetine 10mg Tablet be used in children?
A: Atomoxetine 10mg Tablet should not be used in children and adolescents under 18 years of age unless directed by your doctor. Do not exceed the recommended dose
Q: Can I take Atomoxetine 10mg Tablet with food?
A: No, do not take more than one tablet per day without consulting your doctor.
Q: Can Atomoxetine 10mg Tablet be used for panic attacks?
A: Atomoxetine 10mg Tablet should not be used in patients with a history of panic disorder.
If you’re considering using Strattera to treat attention deficit hyperactivity disorder (ADHD), it’s important to understand its differences from other ADHD medications. Unlike stimulants, which work by increasing blood flow to the brain, Strattera uses a unique mechanism to improve symptoms of ADHD. Unlike stimulants, which do not increase levels of a neurotransmitter, Strattera uses the neurotransmitter norepinephrine to increase norepinephrine levels in the brain.
Here’s an overview of what Strattera is and its uses:
If you’re interested in starting Strattera, please talk to your healthcare provider to determine if Strattera is the right medication for you.
How it worksHow Strattera Works
Strattera belongs to a new class of medications known as stimulants. It’s a type of medication that’s commonly prescribed for the treatment of ADHD. Strattera works by increasing levels of norepinephrine, a neurotransmitter that plays a role in attention and behavior.
Stimulant medications work by increasing levels of norepinephrine, a neurotransmitter that’s found in the brain. Norepinephrine is a neurotransmitter that plays a role in attention and behavior, and Strattera can improve symptoms of ADHD by increasing norepinephrine levels.
Stimulants are typically more effective than stimulants in treating ADHD. These medications can be more trouble than comfort for some individuals, but they don’t have the same side effects or drug interactions as Strattera. This means that some individuals may find Strattera helpful for their symptoms but not for their growth or strength.
Non-stimulant medications, such as Strattera’s, can be effective for some individuals. They can be used to treat symptoms of ADHD or for other reasons, such as stress or anxiety. However, it’s important to talk to your healthcare provider before deciding which medication is the right choice for you.
Here’s an overview of what non-stimulant medications are and their uses:
If you’re considering starting Strattera, it’s important to talk to your healthcare provider to determine which medication is the best fit for your specific needs and symptoms.
The Food and Drug Administration has warned that more than a dozen drugs have been linked to suicidal thoughts and behaviors in children, adolescents, and young adults. One drug, methylphenidate, is linked to dangerous drug levels in children, but no serious side effects have been reported. One of the more serious side effects of the stimulant drug, Ritalin, has been identified in children. The FDA warned the public that Ritalin can cause dangerously high blood pressure in some patients. The FDA also warned the public that more than a dozen other stimulant-related adverse reactions have been identified, including suicidal thoughts, agitation, and behavior. The FDA has asked manufacturers of these stimulants to notify the FDA of any serious drug adverse reactions involving the Ritalin drug.
Drug makers are also asked to disclose the safety information provided to them by the FDA about the risk of suicidal thoughts and behavior in children. In addition to the warning, the FDA has also asked drug manufacturers to provide information about the risk of suicidal behavior in adults. The FDA has also asked drug makers to provide information about the risk of suicidal behavior in adolescents and adults. The FDA has also asked drug manufacturers to provide information about the risk of suicidal behavior in adults.
The FDA is taking a step towards making sure that the warning and risk assessment information provided to manufacturers of Ritalin and other stimulant-related drugs is accurate and up-to-date. A review of the FDA’s latest warning and risk assessment information for methylphenidate is pending and will be posted at a later date. Consumers can contact the FDA’s website at http://www.fda.gov/health/drugs/baclofen/drug/Ritalin.
Dr. Marcia Angell“If you are experiencing a serious side effect or have a medical condition, you should contact a doctor immediately.”
— Dr. Angell, M. D., director of the American College of Cardiology’s Pediatric Endocrinologic Program at the Mayo Clinic in Rochester, Minn.,The FDA warns that there may be increased risk of suicidal thoughts and behavior in young children and adolescents treated with stimulant medications, including Ritalin. The risk is higher in children and young adults. The FDA recommends that drug makers notify the FDA if there are any serious risks associated with the use of stimulant medications.
The FDA issued a warning on February 28, 2003, advising consumers not to purchase any prescription drug, over-the-counter drug, or natural drug products from any drug manufacturer. FDA had not issued an alert on the subject. “All prescription, over-the-counter and prescription medicine is FDA-approved and safe,” the FDA said.
According to the FDA, Ritalin is a stimulant and should be taken only as needed and in the morning. The FDA warns that people taking Ritalin may experience increased risk of suicidal thoughts and behaviors. “It is not known whether Ritalin causes an increase in suicidal thoughts or behaviors.”
Ritalin is marketed as a treatment for Attention Deficit Hyperactivity Disorder (ADHD). The FDA has not identified any studies or clinical trials conducted on Ritalin in children or adolescents. In one study of 19 children and adolescents, Ritalin was associated with a significantly higher risk of suicidality in children and adolescents compared with placebo. However, the study was stopped in September 2005 because of the potential for drug interactions between Ritalin and other drugs.
Susan J. Kupfer, M. D., professor of medicine at the University of Southern California, Los Angeles“The FDA should not allow anyone to make a drug that is dangerous or addictive. The Food and Drug Administration has a responsibility to warnings doctors and patients. The FDA is the only agency that can ensure that a drug is safe and effective for a patient. It must also determine whether the drug is safe and appropriate for a given patient.”
J. B. Miller, Ph. D., associate professor of medicine at the University of Washington, Seattle“The FDA has no responsibility for prescribing and dispensing dangerous medications to patients.”
R. Hoechst, M. D., professor of medicine at the University of California, San Francisco“The FDA is the only agency that can ensure that a drug is safe and effective for a patient. It must also determine whether the drug is appropriate for a given patient.”
K. Schulz, M. D.Consumer Medicine InformationThis leaflet provides important information for patients and caregivers. It may not be updated. It is not intended to replace the advice of a fully discussed healthcare provider. You should not rely on this information or the information shared. You should seek medical advice from your health care professional or your doctor'spocketing agency when developing a treatment plan.
STOCK OF TMP TABLETS ORAL JELLY
TMP TABLETS ORAL JELLY may be used for the treatment of ADHD, narcolepsy and depression in adults and children, or for the treatment of depression in adults.
Treatment of ADHD(ADHD)in adults and children.ADHDis one of the most common psychiatric disorders in children and adolescents. It is estimated that approximately 70,000 children and adolescents are affected by ADHD. The diagnosis of ADHD is made through a structured and supervised clinical approach for adults and children.
The recommended dose for ADHD is 30mg/1 ML (150 mg).
The recommended dose for narcolepsy is 30mg/1 ML (200 mg).
The recommended dose for depression is 30mg/1 ML (300 mg).
The recommended dose for ADHD is 40mg/1 ML (300 mg).
HOW STRATTERA WORKS
The recommended dose of STRATTERA is 30 mg/1 ML (150 mg).
SIDE EFFECTS
See package leaflet for further information.
FINDING MY DOCTOR WORKS
CLINICAL ACTIONS for ADHDADHD in adults
ADHD in children
See package leaflet for more information.
Treatment of ADHD in adults and children
The missed dose of STRATTERA should be taken as soon as possible. If it is almost time for the next dose, then take the missed dose as soon as you remember. If it is almost time for the next dose, then take the missed dose as soon as possible. Do not take 2 doses at once.
See package leaflet for information about drug interactions.
The information in this leaflet is not intended to cover all possible uses, directions, precautions, warnings and precautions of other medicines.
You should check with your doctor, nurse or pharmacist if you are not sure about what other information you may have. You should also let your doctor know if you are taking any other medicines, including any that you buy without a prescription from your pharmacy.
Stade de France Pharmacy